These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Transvaginal ultrasonography at early pregnancy cannot be used alone for targeted organ ultrasonographic examination in a high-risk population. Yagel S; Achiron R; Ron M; Revel A; Anteby E Am J Obstet Gynecol; 1995 Mar; 172(3):971-5. PubMed ID: 7892892 [TBL] [Abstract][Full Text] [Related]
48. [Embryo-fetal ultrasonographic diagnosis in the early pregnancy using transvaginal echography]. Guariglia L; Rosati P Minerva Ginecol; 1997 Mar; 49(3):95-108. PubMed ID: 9173346 [TBL] [Abstract][Full Text] [Related]
49. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183 [TBL] [Abstract][Full Text] [Related]
50. Maternal Anxiety Related to Prenatal Diagnoses of Fetal Anomalies That Require Surgery. Wilpers AB; Kennedy HP; Wall D; Funk M; Bahtiyar MO J Obstet Gynecol Neonatal Nurs; 2017; 46(3):456-464. PubMed ID: 28390224 [TBL] [Abstract][Full Text] [Related]
53. Screening for congenital fetal anomalies in low risk pregnancy: the Kenyatta National Hospital experience. Onyambu CK; Tharamba NM BMC Pregnancy Childbirth; 2018 May; 18(1):180. PubMed ID: 29792180 [TBL] [Abstract][Full Text] [Related]
54. [Fetal malformations diagnosed using ultrasonography during tri-test. A retrospective study of 1633 fetuses]. Pepe F; Montaperto A; Insolia G; Evola G; Recupero S Minerva Ginecol; 2001 Apr; 53(2):87-91. PubMed ID: 11319501 [TBL] [Abstract][Full Text] [Related]
55. [Pregnancy outcome in 1,252 fetuses after nuchal translucency measurement in the 1st trimester]. Horner E; Holzgreve W; Batucan C; Tercanli S Praxis (Bern 1994); 2002 Feb; 91(7):261-5. PubMed ID: 11883361 [TBL] [Abstract][Full Text] [Related]
56. Feasibility of the second-trimester fetal ultrasound examination in an unselected population at 18, 20 or 22 weeks of pregnancy: a randomized trial. Schwärzler P; Senat MV; Holden D; Bernard JP; Masroor T; Ville Y Ultrasound Obstet Gynecol; 1999 Aug; 14(2):92-7. PubMed ID: 10492867 [TBL] [Abstract][Full Text] [Related]
57. Prevalence of major congenital anomalies at King Fahad Medical City in Saudi Arabia: a tertiary care centre-based study. Sallout B; Obedat N; Shakeel F; Mansoor A; Walker M; Al-Badr A Ann Saudi Med; 2015; 35(5):343-51. PubMed ID: 26506967 [TBL] [Abstract][Full Text] [Related]
58. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084 [TBL] [Abstract][Full Text] [Related]
59. Improved antenatal detection of congenital anomalies in women with pre-gestational diabetes: population-based cohort study. Newham JJ; Glinianaia SV; Tennant PW; Rankin J; Bell R Diabet Med; 2013 Dec; 30(12):1442-8. PubMed ID: 23909859 [TBL] [Abstract][Full Text] [Related]
60. Prenatal ultrasound findings of lissencephaly associated with Miller-Dieker syndrome and comparison with pre- and postnatal magnetic resonance imaging. Fong KW; Ghai S; Toi A; Blaser S; Winsor EJ; Chitayat D Ultrasound Obstet Gynecol; 2004 Dec; 24(7):716-23. PubMed ID: 15586369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]